CIBC Bancorp USA’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
Other funds holding CAH
CIBC Bancorp USA's CAH Position: Q3 2026 in Review
CIBC Bancorp USA reduced its Cardinal Health (CAH) stake by 21% in Q3 2026, selling an estimated $25.8M and leaving 424,861 shares worth $94.8M. The position accounts for 0.12% of the portfolio, ranked #164.
CIBC Bancorp USA first reported a position in CAH in Q3 2025 and has held it in 4 quarters since. The position peaked at $187M in Q1 2026. 1,272 funds tracked by Wall St. Rank hold CAH as of Q3 2026.
- CIBC Bancorp USA held 424,861 shares of Cardinal Health worth $94.8M as of Q3 2026.
- CIBC Bancorp USA sold 110,850 Cardinal Health shares in Q3 2026, an estimated $25.8M.
- Cardinal Health made up 0.12% of CIBC Bancorp USA's portfolio in Q3 2026, its #164 holding.
- CIBC Bancorp USA first reported a position in Cardinal Health in Q3 2025 and has held it in 4 quarters since.
- CIBC Bancorp USA's Cardinal Health position peaked at $187M in Q1 2026.
- 1,272 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.
Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.